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Summary Very late stent thrombosis (VLST) after implantation of a drug-eluting stent (DES)
is a rare but catastrophic complication and the mechanisms are not completely understood. We
describe a 76-year-old patient with recurrent VLST of DES that developed at 13 and 23 months
after the initial catheter procedure of DES implantation under the cessation of dual antiplatelet
therapy. Optical coherence tomography (OCT) observation revealed small stent area of a DES.tomography Based on the OCT ﬁndings, balloon angioplasty for expansion of the DES was performed and
angiographic Thrombolysis In Myocardial Infarction grade 3 ﬂow was subsequently obtained.
Small stent area is considered a signiﬁcant factor in acute or subacute stent thrombosis accord-
ing to previous reports. The present report shows that small stent area of DES may be regarded
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ntroductionrug-eluting stents (DESs) are widely applied to reduce
n-stent restenosis and target lesion revascularization
ompared with bare metal stents (BMS). However, very
ate stent thrombosis (VLST) occurring >1 year after stent
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mplantation is associated with delayed healing and subse-
uent lack of endothelialization and has become a major
linical concern [1,2] because VLST frequently portends
erious cardiac events such as sudden death and acute
yocardial infarction. The mechanism of VLST of DES may
e multi-factorial, and two important mechanisms are
essation of dual antiplatelet therapy (DAT) and incomplete
tent apposition (ISA), including late acquired ISA [3—6].
ew case reports have described recurrent VLST of DES
7,8], and possible causes include the cessation of DAT and
SA accompanied by delayed endothelialization. However,
he present report describes a patient in which recurrent
Published by Elsevier Ireland Ltd. All rights reserved.
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Figure 1 Angiographic and optical coherence tomography (OCT) ﬁndings of recurrent thrombotic occlusion of a paclitaxel-eluting
stent (PES). (A) Coronary angiograms show total occlusion at the proximal edge of the stent in the left anterior descending artery.
ge. (C
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d(B) Massive thrombotic lesion (arrows) on longitudinal OCT ima
thrombus (arrows) and obvious small stent area (arrowheads). A
minimal stent area was 2.23mm2. BMS, bare metal stent.
VLST of DES was caused by cessation of DAT and small stent
area that was conﬁrmed by ﬁndings of optical coherence
tomography (OCT).Case report
A 76-year-old man with hypertension and dyslipidemia was
admitted to our hospital with severe chest pain on August
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Figure 2 Fluoroscopic images during balloon angioplasty. (A) Non-c
indented (arrow). (B) Indentation has disappeared after high-pressu) and (D) Cross-sectional OCT images also indicate protruding
ugh thrombus interfered with OCT measurements, measurable
th 2009. He had previously undergone percutaneous coro-
ary intervention (PCI) three times due to ischemic heart
isease at a local community hospital. The ﬁrst PCI com-
®rised BMS (Liberte 3.0mm× 24mm; Boston Scientiﬁc,
atick, MA, USA) implantation into the proximal left ante-
ior descending artery (LAD) for unstable angina pectoris in
une 2007. The second was implantation with a paclitaxel-
luting stent (PES; Taxus-Express2® 3.0mm× 28mm; Boston
ompliant balloon (3.25mm× 12mm) inﬂated at 20 atm remains
re (30 atm) inﬂation (arrow).
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cientiﬁc) for BMS restenosis in September 2007 under
spirin (100mg/day) and clopidogrel (75mg/day) admin-
stration. BMS was completely covered by PES. The third
CI was balloon angioplasty for a diagnosis of ST ele-
ation myocardial infarction (STEMI) due to VLST of PES
n October 2008, 3 days after clopidogrel discontinua-
ion.
He was admitted to the same hospital 23 months (August
th 2009) after PES implantation (2nd PCI) because of
elena due to colonic diverticulitis. DAT was discontinued
fter admission and STEMI occurred again on the follow-
ng day, when he was transferred from that hospital to our
nstitution. Coronary angiography revealed total occlusion
t the proximal edge of the PES in the proximal LAD, and
ecurrent VLST of the PES was documented. Massive throm-
us inside the PES and obvious small lumen area of the
ES were identiﬁed by OCT (ImageWire®, LightLab Imag-
ng, Westford, MA, USA). OCT images indicated small stent
rea with uncovered struts and measurable minimal stent
2rea was 2.23mm , despite the fact that thrombus with
ackscattering interfered with precise measurements for
tent area (Fig. 1). Although intracoronary thrombectomy
as attempted before OCT procedure, a thrombectomy
atheter did not pass through the stent because small
a
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igure 3 Angiographic and optical coherence tomography (OCT) ﬁ
olysis In Myocardial Infarction grade 3 ﬂow without ﬁlling defects.
n longitudinal OCT image. (C) and (D) Cross-sectional OCT images
espite protrusion mass with signal attenuation suspected mural thr
tent.N. Kobayashi et al.
tent area possibly disturbed its delivery. Balloon angio-
lasty with a non-compliant balloon (Quantum Maverick®
.25mm× 12mm; Boston Scientiﬁc) was performed after
hrombectomy. The balloon was ﬁrstly inﬂated at 20 atm to
ilate the stent, but the balloon remained indented. There-
fter, the balloon was inﬂated at 30 atm over the rated
urst pressure (Fig. 2). This strategy resulted in optimal PES
xpansion on OCT images and TIMI grade 3 ﬂow on angiogra-
hy (Fig. 3). The patient was discharged on day 15 without
ajor adverse cardiac events, and the clinical course of the
atient was uneventful without taking aspirin.
iscussion
his is the ﬁrst report to show the mechanisms of recur-
ent VLST of DES based on OCT ﬁndings of obvious small
tent area. In this case, the leading mechanism of recur-
ent VLST of DES is cessation of DAT, and small stent area
lso contributes to repeat VLST. It was speculated that stent
nderexpansion occurred at the 2nd PCI (PES implantation),
lthough there were no available data on IVUS or OCT during
he procedures of 1st, 2nd, and 3rd PCI because they were
erformed at another institution.
ndings after balloon angioplasty. (A) Angiograms show Throm-
(B) Lumen dilation at proximal edge of stent (arrows) evident
show optimal stent expansion (minimal stent area, 5.43mm2)
ombus (arrows). BMS, bare metal stent; PES, paclitaxel-eluting
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Stent thrombosis is classiﬁed according to elapsed time
after stent implantation as acute (within 24 h), subacute
(1—30 days later), late (LST; 30 days to 1 year later),
and very late (VLST; >1 year later) [9]. The incidence of
VLST is slightly higher for DES than for BMS because of
delayed neointimal healing and endothelialization associ-
ated with DES [1,2]. Accumulated ﬁndings emphasize that
the mechanisms of stent thrombosis are multi-factorial,
such as the discontinuation of DAT [10,11], stent underex-
pansion [12,13], ISA [3—6], bifurcation stenting [10,11], and
low ejection fraction of the left ventricle [10]. ISA is the
most important cause, especially of VLST of DES because
it results in delayed arterial healing after DES implantation
[3—6]. Although there have not been many reports of recur-
rent VLST of DES [7,8], discontinuation of DAT and ISA are
recognized causes of recurrent VLST [7,8].
Discontinuing the antiplatelet therapy was one trigger
of the VLST of PES in the present patient. Clopidogrel
was interrupted at the ﬁrst stent thrombosis, and DAT
was discontinued before the second episode. An additional
cause was small stent area, which was clearly revealed
by the OCT examination and is a known cause of acute
and subacute stent thrombosis [12]. Nevertheless, small
stent area can lead to recurrent VLST of DES under condi-
tions of delayed endothelialization or incomplete neointimal
healing. Although small lumen area of BMS can lead to
restenosis accompanied by neointimal healing that may
occur at over 30 days after stenting, VLST might not arise
from small lumen area of BMS. Therefore, we speculated
that the combination of small stent area, delayed arte-
rial healing characterized by subsequent DES deployment,
and discontinuation of antiplatelet therapy foreshadowed
the recurrent VLST in the present patient. Aggressive stent
expansion might not be necessary for DES due to lower late
loss compared with BMS, but obvious DES underexpansion
is one important factor involved in VLST. The present case
is not serial but single point of OCT observation. There-
fore, there was a limitation to clarify previous status of
the implanted DES for treatment of BMS restenosis, although
we speculate the cause of small PES lumen area was stent
underexpansion. For this patient, restudy using OCT has not
been achieved because of no evident myocardial ischemia.
Finally, the current OCT images suggest that optimal expan-
sion of an implanted DES is required to prevent VLST. In
addition, we should take care to interrupt DAT especially
in cases of the underexpansion of DES.References
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